Unibest
← Back to patent-cliff list

CAS 865999-70-8

N-((S)-2-((1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-1-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-2-oxoethyl)-2,2,2-trifluoroacetamide

Codes: SAXA-048

Application context (from source-drug indications)

Type 2 diabetesDapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideType 2 diabetesSaxagliptin HydrateHypoglycaemiaSaxagliptin HydrateType 1 diabetesSaxagliptin HydrateDiabetesSaxagliptin Hydrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Dapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideTier C — Watch / trade-
Saxagliptin HydrateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.